Constantine Tam

CLL: Q&A with Constantine Tam​

Professor Tam discusses some common chronic lymphocytic leukemia (CLL) disease characteristics and expected treatment outcomes. He introduces the role of Bruton's tyrosine kinase inhibition (BTKi) in CLL, challenges in their use, and hopes for the future treatment of CLL.
Vídeos
15 dez 2021
memo

Memo inOncology - ASH 2021 congress report

Report on the latest developments in Bruton's tyrosine kinase inhibition (BTKi) and B-cell lymphoma 2 inhibition (BCL2i) in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and other B-cell malignancies presented at ASH 2021.
Kits de diapositivos
11 dez 2021
Queira inicie sessão ou registe-se para aceder à transferência
Carregar mais